PL353137A1 - Sferyczne aglomeraty telitromycyny, sposób ich wytwarzania i ich zastosowanie w wytwarzaniu form farmaceutycznych - Google Patents

Sferyczne aglomeraty telitromycyny, sposób ich wytwarzania i ich zastosowanie w wytwarzaniu form farmaceutycznych

Info

Publication number
PL353137A1
PL353137A1 PL00353137A PL35313700A PL353137A1 PL 353137 A1 PL353137 A1 PL 353137A1 PL 00353137 A PL00353137 A PL 00353137A PL 35313700 A PL35313700 A PL 35313700A PL 353137 A1 PL353137 A1 PL 353137A1
Authority
PL
Poland
Prior art keywords
preparation
production
pharmaceutical forms
clusters
spherical
Prior art date
Application number
PL00353137A
Other languages
English (en)
Other versions
PL204100B1 (pl
Inventor
Jean-Yves Godard
Valerie Rognon-Ravaux
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL353137(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of PL353137A1 publication Critical patent/PL353137A1/pl
Publication of PL204100B1 publication Critical patent/PL204100B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL353137A 1999-08-26 2000-08-28 Sposób wytwarzania sferycznych aglomeratów telitromycyny i ich zastosowanie PL204100B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (2)

Publication Number Publication Date
PL353137A1 true PL353137A1 (pl) 2003-10-20
PL204100B1 PL204100B1 (pl) 2009-12-31

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353137A PL204100B1 (pl) 1999-08-26 2000-08-28 Sposób wytwarzania sferycznych aglomeratów telitromycyny i ich zastosowanie

Country Status (34)

Country Link
US (1) US6825218B1 (pl)
EP (1) EP1212336B1 (pl)
JP (1) JP4871467B2 (pl)
KR (1) KR100718222B1 (pl)
CN (1) CN1183151C (pl)
AR (1) AR025398A1 (pl)
AT (1) ATE255590T1 (pl)
AU (1) AU774385B2 (pl)
BR (1) BR0013569B1 (pl)
CA (1) CA2382497C (pl)
CO (1) CO5190666A1 (pl)
CZ (1) CZ2002594A3 (pl)
DE (1) DE60006976T2 (pl)
DK (1) DK1212336T3 (pl)
EA (1) EA005080B1 (pl)
ES (1) ES2209970T3 (pl)
FR (1) FR2797875B1 (pl)
HK (1) HK1049167B (pl)
HR (1) HRP20020167B1 (pl)
HU (1) HU229075B1 (pl)
IL (2) IL148128A0 (pl)
ME (2) MEP20108A (pl)
MX (1) MXPA02001988A (pl)
NO (1) NO322622B1 (pl)
PL (1) PL204100B1 (pl)
PT (1) PT1212336E (pl)
RS (1) RS50433B (pl)
SI (1) SI1212336T1 (pl)
SK (1) SK287588B6 (pl)
TR (1) TR200200506T2 (pl)
TW (1) TWI272949B (pl)
UA (1) UA73523C2 (pl)
WO (1) WO2001014393A2 (pl)
ZA (1) ZA200201599B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (en) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1610878B1 (en) * 2003-02-21 2014-09-03 University Of Bath Process for the production of particles
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE31635T1 (de) * 1983-06-22 1988-01-15 Univ Ohio State Res Found Herstellung von feinen materialien.
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
HK1049167B (zh) 2005-08-19
CZ2002594A3 (cs) 2002-09-11
EP1212336A2 (fr) 2002-06-12
BR0013569A (pt) 2002-05-14
CA2382497C (fr) 2011-06-28
HK1049167A1 (en) 2003-05-02
FR2797875B1 (fr) 2001-10-19
CN1371386A (zh) 2002-09-25
DK1212336T3 (da) 2004-03-15
HRP20020167A2 (en) 2003-06-30
ES2209970T3 (es) 2004-07-01
ZA200201599B (en) 2003-04-30
PT1212336E (pt) 2004-04-30
WO2001014393A3 (fr) 2001-06-21
KR100718222B1 (ko) 2007-05-15
DE60006976T2 (de) 2004-10-21
HUP0202842A3 (en) 2003-03-28
KR20020033771A (ko) 2002-05-07
MEP20108A (en) 2010-06-10
AU774385B2 (en) 2004-06-24
PL204100B1 (pl) 2009-12-31
SI1212336T1 (en) 2004-04-30
ME00112B (me) 2010-10-10
NO20020926D0 (no) 2002-02-26
SK287588B6 (sk) 2011-03-04
AU7018100A (en) 2001-03-19
CN1183151C (zh) 2005-01-05
EA005080B1 (ru) 2004-10-28
JP4871467B2 (ja) 2012-02-08
MXPA02001988A (es) 2002-08-20
RS50433B (sr) 2009-12-31
JP2003507484A (ja) 2003-02-25
HUP0202842A2 (hu) 2003-01-28
YU13202A (sh) 2004-09-03
EA200200294A1 (ru) 2002-08-29
TWI272949B (en) 2007-02-11
TR200200506T2 (tr) 2002-08-21
CA2382497A1 (fr) 2001-03-01
NO322622B1 (no) 2006-11-06
UA73523C2 (uk) 2005-08-15
CO5190666A1 (es) 2002-08-29
WO2001014393A2 (fr) 2001-03-01
AR025398A1 (es) 2002-11-27
EP1212336B1 (fr) 2003-12-03
IL148128A (en) 2006-10-31
SK2532002A3 (en) 2002-09-10
HRP20020167B1 (en) 2006-06-30
IL148128A0 (en) 2002-09-12
NO20020926L (no) 2002-02-26
US6825218B1 (en) 2004-11-30
DE60006976D1 (de) 2004-01-15
FR2797875A1 (fr) 2001-03-02
ATE255590T1 (de) 2003-12-15
BR0013569B1 (pt) 2014-02-25
HU229075B1 (hu) 2013-07-29

Similar Documents

Publication Publication Date Title
HUP0201010A2 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
CZ200151A3 (en) Sulfur-substituted N-arylamides of sulfonylaminocarboxylic acid, process of their preparation, their use and pharmaceutical preparations in which they are comprised
IL144519A0 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
IL153920A (en) Somatostatin analogues, processes for their production, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
IL144448A0 (en) Inorganic shaped bodies and methods for their production and use
HUP0203425A3 (en) Quinazoline derivatives, process for their preparation and their use
EP1338198A4 (en) PROCESS FOR MAKING A MOUSE SUITABLE FOR THE RECORDING, DIFFERENTIATION AND PROLIFERATION OF HETEROGENIC CELLS, THE MOUSE PRODUCED THEREOF AND THEIR USE
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
HUP0105148A2 (hu) Telmisartan polimorfja, eljárás előállítására és alkalmazása gyógyszerkészítmény előállítására
IL214387A (en) History of tryptamine, method for their preparation and use for the preparation of pharmaceuticals and for the preparation of tryptamine
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
PL353137A1 (pl) Sferyczne aglomeraty telitromycyny, sposób ich wytwarzania i ich zastosowanie w wytwarzaniu form farmaceutycznych
HRP20031067A2 (en) Pharmaceutical formulation having masked taste and method for the production thereof
AU2002215868A1 (en) Protein shaped body and method for the production thereof according to the nmmo method
CZ20021489A3 (cs) N-guanidinoalkylamidy, jejich příprava, pouľití a farmaceutické směsi, které je obsahují
TWI318211B (en) Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
HUP0203310A3 (en) Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof
PL1466604T3 (pl) Nowe pochodne izochinoliny, sposób ich wytwarzania i ich zastosowanie do leczenia zaburzeń układu melatoninergicznego
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
IL140739A0 (en) Glyceryl trinitrate-containing preparation, method for its production, and its use
PL375762A1 (pl) Stosowany donosowo preparat farmaceutyczny i jegowytwarzanie
AU2795202A (en) Klainetin and derivatives thereof, method for their production and the use of the same
AU5747699A (en) Antipollution plant complex, production process and utilization of said complex in the preparation of pharmaceutical and/or cosmetic compositions